BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6958253)

  • 1. Carcinoembryonic antigen in ovarian cancer: correlation of concentrations in tumour tissue, cyst fluid, ascitic fluid and peripheral blood.
    Khoo SK; Hill R; Daunter B; Mackay EV
    Aust N Z J Obstet Gynaecol; 1982 May; 22(2):65-70. PubMed ID: 6958253
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of the physicochemical properties of carcinoembryonic antigen in extracts of tumour tissue, ascitic and cyst fluid from ovarian cancer.
    Hill R; Daunter B; Magon H; Khoo SK; Mackay EV
    Aust J Exp Biol Med Sci; 1981 Aug; 59(4):469-76. PubMed ID: 7295221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [CEA determination in aspired fluid of cystic ovarian tumors and ovarian cysts and in ascites and serum samples of patients with ovarian tumors].
    Kunze M; Büttner HH; Strache RR; Voss P; Briese V; Schrodt U
    Zentralbl Gynakol; 1988; 110(16):1006-12. PubMed ID: 3188713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Case of Krukenberg's tumor originating in the stomach with a marked increase in the ascitic carcinoembryonic antigen (CEA) level in comparison with that of the blood].
    Kohno H; Morimoto S; Onishi T; Tahara Y; Kumahara Y
    Nihon Naika Gakkai Zasshi; 1983 Apr; 72(4):462-7. PubMed ID: 6310009
    [No Abstract]   [Full Text] [Related]  

  • 5. Carcinoembryonic antigen in ovarian epithelial cystadenocarcinomas: the prognostic value of tumor and serial plasma determinations.
    van Nagell JR; Donaldson ES; Gay EC; Sharkey RM; Rayburn P; Goldenberg DM
    Cancer; 1978 Jun; 41(6):2335-40. PubMed ID: 350376
    [No Abstract]   [Full Text] [Related]  

  • 6. A study of cyst fluid and plasma carcinoembryonic antigen in patients with cystic ovarian neoplasms.
    van Nagell JR; Pletsch QA; Goldenberg DM
    Cancer Res; 1975 Jun; 35(6):1433-7. PubMed ID: 805659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of tumour-associated immunoglobulins from ascitic fluid.
    Hill R; Daunter B; Khoo SK; MacKay EV
    Br J Cancer; 1978 Jul; 38(1):154-7. PubMed ID: 687514
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumour markers in ovarian cancer.
    van Nagell JR
    Clin Obstet Gynaecol; 1983 Aug; 10(2):197-212. PubMed ID: 6193919
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of biochemical markers between benign and malignant ovarian cysts.
    Knight JA; Wu JT; Miya T; Knight DP
    Clin Physiol Biochem; 1986; 4(2):130-5. PubMed ID: 3516514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nature of carcinoembryonic antigen purified from malignant ascitic fluid of serous cystadenocarcinoma of the ovary.
    Hill R; Daunter B; Khoo SK; Mackay EV
    Mol Immunol; 1981 Jul; 18(7):647-53. PubMed ID: 7300840
    [No Abstract]   [Full Text] [Related]  

  • 11. [Placental protein 12 (PP 12) in cyst and peritoneal fluids and serum samples of patients with ovarian cysts and cystic ovarian tumors].
    Strache RR; Göcze PM; Szábo DG; Büttner HH; Briese V; Kunze M; Csaba IF; Röpcke G
    Zentralbl Gynakol; 1989; 111(11):749-54. PubMed ID: 2781888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early diagnosis of ovarian cancer.
    Popkin DR
    Can Med Assoc J; 1979 May; 120(9):1106-8. PubMed ID: 445304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinogen degradation products (F.D.P.) in ascitic fluid of patients affected by ovarian cancer.
    Paternoster D; Maggino T; Valente S; Pengo V; Marchesoni D
    Eur J Gynaecol Oncol; 1981; 2(3):127-8. PubMed ID: 7347682
    [No Abstract]   [Full Text] [Related]  

  • 14. Demonstration of tumor-associated immunoglobulin G isolated from immune complexes in ascitic fluid of ovarian cancer.
    Silburn PA; Khoo SK; Hill R; Daunter B; Mackay EV
    Diagn Immunol; 1984; 2(1):30-5. PubMed ID: 6209058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CA 125 and carcinoembryonic antigen levels in cyst fluid, ascites and serum of patients with ovarian neoplasms.
    Harłozińska A; Bar JK; Gawlikowski W; Richter R; Cisło M
    Ann Chir Gynaecol; 1991; 80(4):368-75. PubMed ID: 1667567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoembryonic antigen isotypes in tissue sections and loose cyst fluid cells of ovarian neoplasms.
    Harłozińska A; Bar JK; Jothy S; Sedlaczek P; Slesak B; Richter R
    Tumour Biol; 1993; 14(1):1-8. PubMed ID: 7684152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved specificity of the CA 125 enzyme immunoassay for ovarian carcinomas by use of the ratio of CA 125 to carcinoembryonic antigen.
    Wu JT; Miya T; Knight JA; Knight DP
    Clin Chem; 1988 Sep; 34(9):1853-7. PubMed ID: 2458203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunochemical identification of carcinoembryonic antigen in ovarian adenocarcinoma and pseudomucinous cystoma extracts].
    Tatarinov IuS; Kalashnikov VV; Borisenko SA; Griaznova IM; Vasil'eva NN
    Biull Eksp Biol Med; 1975 Jan; 79(1):50-3. PubMed ID: 803383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral and ovarian venous concentrations of gonadal steroids and CEA in women with ovarian tumors.
    Jeppsson S; Kullander S; Rannevik G
    Acta Obstet Gynecol Scand; 1982; 61(3):209-12. PubMed ID: 6812383
    [No Abstract]   [Full Text] [Related]  

  • 20. [Production of carcinoembryonic antigen by a benign cystadenoma of the ovary. Association with gelatinous disease of the peritoneum].
    Pagé M; Bertrand G; Dalifard I; Ronceray J; Daver A; Esperandieu O; Saint-André JP
    Presse Med; 1984 Feb; 13(8):503. PubMed ID: 6230636
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.